Other languages Mayne Pharma Group Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:53 2024-05-31 am EDT			5-day change	1st Jan Change
5.04 ^AUD	+0.40%		-8.03%	-18.05%

May. 24	Mayne Pharma Reiterates H2 FY24 Outlook in Wake of Change Healthcare Cyberattack	MT
May. 10	Mayne Pharma Group's Nextstellis Oral Contraceptive Receives Two Additional US Patents	MT

Mayne Pharma Reiterates H2 FY24 Outlook in Wake of Change Healthcare Cyberattack	May. 23
Mayne Pharma Group's Nextstellis Oral Contraceptive Receives Two Additional US Patents	May. 09
Lagere omzet Mithra ondanks hogere productomzet	Mar. 08
Mithra zet zichzelf in de etalage	Mar. 05
Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15%	Feb. 25
Mayne Pharma Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 25
Brussel schudt tegenvallende inflatie data van zich af	Feb. 17
Mithra Pharmaceuticals Exits Stake in Mayne Pharma	Feb. 16
Brussel sluit in het groen	Feb. 15
Chemie en zorgvastgoed trekken de kop	Feb. 15
Kleine winsten in Brussel	Feb. 15
Brusselse beurs opent in het groen	Feb. 15
Mithra verkoopt Mayne Pharma	Feb. 15
An undisclosed buyer acquired a 5.06% stake in Mayne Pharma Group Limited from Mithra Pharmaceuticals SA for AUD 21 million	Feb. 14
Mayne Pharma Group Limited Approves Election of Anne Lockwood	Nov. 29
Mithra Pharmaceuticals Obtains US Patent for Contraceptive Pill	Nov. 07
Aanvullend Amerikaans patent voor Mithra	Nov. 07
Mayne Pharma Gets Additional US Patent for Contraceptive	Nov. 06
Mayne Pharma Gets Go-Ahead for Resignation of EY as Auditor	Nov. 03
Mayne Pharma Acquires Dermatological Medication	23-09-26

No results for this search